Qrons OTC Stock Executives
| QRON Stock | USD 0.18 0.01 5.26% |
Qrons employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Qrons' management performance can provide insight into the firm performance.
| Jonah Meer Insider CEO, CoFounder |
| Ido Merfeld Insider Pres CoFounder |
Qrons |
Qrons Management Team Effectiveness
The company has return on total asset (ROA) of (14.9238) % which means that it has lost $14.9238 on every $100 spent on assets. This is way below average. Qrons' management efficiency ratios could be used to measure how well Qrons manages its routine affairs as well as how well it operates its assets and liabilities.Qrons Workforce Comparison
Qrons Inc is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 545. Qrons adds roughly 2.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Qrons Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Qrons Inc Price Series Summation is a cross summation of Qrons price series and its benchmark/peer.
Qrons Notable Stakeholders
A Qrons stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Qrons often face trade-offs trying to please all of them. Qrons' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Qrons' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jonah Meer | CEO, CoFounder | Profile | |
| Ido Merfeld | Pres CoFounder | Profile |
About Qrons Management Performance
The success or failure of an entity such as Qrons Inc often depends on how effective the management is. Qrons management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Qrons management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Qrons management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York. Qrons operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
The data published in Qrons' official financial statements typically reflect Qrons' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Qrons' quantitative information. For example, before you start analyzing numbers published by Qrons accountants, it's essential to understand Qrons' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Qrons Workforce Analysis
Traditionally, organizations such as Qrons use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Qrons within its industry.Qrons Manpower Efficiency
Return on Qrons Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 534K | |
| Net Loss Per Executive | 534K |
Other Information on Investing in Qrons OTC Stock
Qrons financial ratios help investors to determine whether Qrons OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Qrons with respect to the benefits of owning Qrons security.